Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer

Clinical trial NCT00331682 · COMPLETED

Trial details

NCT number: NCT00331682
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2006-03-01
Primary completion: 2008-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.